Repare Therapeutics Inc. (RPTX)
USD 1.32
(3.13%)
USD 1.32
(3.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -127.15 Million | 322 Thousand | -85.79 Million | -6.08 Million | -18.42 Million | -12.61 Million |
| Net Income | -93.79 Million | -29.04 Million | -106.9 Million | -53.41 Million | -27.21 Million | -14.28 Million |
| Depreciation & Amortization | 1.95 Million | 1.97 Million | 1.47 Million | 897 Thousand | 605 Thousand | 407 Thousand |
| Deferred income taxes | -1.93 Million | 3.62 Million | 149 Thousand | 588 Thousand | -629 Thousand | 306 Thousand |
| Stock-based compensation | 25.06 Million | 19.69 Million | 12.82 Million | 2.53 Million | 511 Thousand | 306 Thousand |
| Change in working capital | -55.18 Million | 8.02 Million | 4.79 Million | 42.42 Million | 6.58 Million | -484 Thousand |
| Other non-cash items | -3.25 Million | -3.94 Million | 1.87 Million | 890 Thousand | 1.71 Million | 1.13 Million |
| Investing Cash Flow | 78.04 Million | -175.77 Million | -1.67 Million | -9.76 Million | -1.3 Million | -583 Thousand |
| Investments in PPE | -1.93 Million | -602 Thousand | -1.69 Million | -2.23 Million | -1.3 Million | -583 Thousand |
| Acquisitions | -79.97 Million | 175.17 Million | 40 Thousand | - | - | - |
| Investment purchases | -179.02 Million | -256.57 Million | -7.47 Million | -7.52 Million | - | - |
| Sales/Maturities of investments | 259 Million | 81.4 Million | 7.45 Million | - | - | - |
| Other Investing Activities | 79.97 Million | -175.17 Million | 14 Thousand | -7.52 Million | - | - |
| Financing Cash Flow | 842 Thousand | 880 Thousand | 95.55 Million | 247.84 Million | 103.24 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 689 Thousand | 433 Thousand | 283 Thousand | - | - | - |
| Common Stock Issuance | 842 Thousand | 880 Thousand | 95.55 Million | 232.04 Million | 103.24 Million | - |
| Other Financing Activities | 842 Thousand | 880 Thousand | 95.55 Million | 15.79 Million | 103.24 Million | - |
| Accounts receivables | -216 Thousand | -1.52 Million | 2.99 Million | -2.94 Million | -1.91 Million | -485 Thousand |
| Accounts payables | 1.93 Million | -1.34 Million | 152 Thousand | 17 Thousand | 833 Thousand | 10 Thousand |
| Inventory | - | - | -2.99 Million | 2.94 Million | 1.91 Million | - |
| Other working capital | -56.9 Million | 10.89 Million | 4.63 Million | 42.4 Million | 5.75 Million | -494 Thousand |
| Cash at beginning of period | 159.52 Million | 334.42 Million | 326.39 Million | 95 Million | 10.92 Million | 24.38 Million |
| Cash at end of period | 111.26 Million | 159.52 Million | 334.42 Million | 326.39 Million | 95 Million | 10.92 Million |
| Capital Expenditure | -1.93 Million | -602 Thousand | -1.69 Million | -2.23 Million | -1.3 Million | -583 Thousand |
| Effect of forex changes on cash | 22 Thousand | -330 Thousand | -54 Thousand | -604 Thousand | 566 Thousand | -259 Thousand |
| Net cash flow / Change in cash | -48.25 Million | -174.9 Million | 8.03 Million | 231.39 Million | 84.07 Million | -13.46 Million |
| Free Cash Flow | -129.09 Million | -280 Thousand | -87.48 Million | -8.32 Million | -19.73 Million | -13.2 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -34.77 Million | 13.16 Million | -28.03 Million | -93.79 Million | -18.87 Million | -11.94 Million |
| Depreciation & Amortization | 488 Thousand | 501 Thousand | 506 Thousand | 1.95 Million | 498 Thousand | 506 Thousand |
| Deferred income taxes | - | - | -10.79 Million | -1.93 Million | -1.87 Million | -2.09 Million |
| Stock-based compensation | 6.51 Million | 6.47 Million | 6.35 Million | 25.06 Million | 6.37 Million | 6.26 Million |
| Change in working capital | -1.64 Million | -7.5 Million | -5.89 Million | -55.18 Million | -19.54 Million | -27.62 Million |
| Other non-cash items | 6.24 Million | 1.23 Million | 9.7 Million | -3.25 Million | 551 Thousand | 545 Thousand |
| Investing Cash Flow | 7.11 Million | -20.31 Million | 31.87 Million | 78.04 Million | 24.49 Million | 28.35 Million |
| Investments in PPE | - | - | -398 Thousand | -1.93 Million | - | -1.06 Million |
| Acquisitions | - | - | -32.27 Million | -79.97 Million | - | -29.41 Million |
| Investment purchases | -12.88 Million | -89.33 Million | -4.72 Million | -179.02 Million | -28.5 Million | -47.08 Million |
| Sales/Maturities of investments | 20 Million | 69.01 Million | 37 Million | 259 Million | 53 Million | 76.5 Million |
| Other Investing Activities | - | -20.31 Million | 32.27 Million | 79.97 Million | 24.49 Million | 29.41 Million |
| Financing Cash Flow | - | 375 Thousand | 105 Thousand | 842 Thousand | 284 Thousand | 40 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 11.28 Billion | 358 Thousand | -10.03 Billion | 689 Thousand | - | - |
| Common Stock Issuance | - | 375 Thousand | 105 Thousand | 842 Thousand | 284 Thousand | 40 Thousand |
| Other Financing Activities | - | 17 Thousand | 105 Thousand | 842 Thousand | 284 Thousand | 40 Thousand |
| Accounts receivables | -200 Thousand | 1.11 Million | -775 Thousand | -216 Thousand | 1.54 Million | 1.75 Million |
| Accounts payables | 354 Thousand | 4.43 Million | -2.65 Million | 1.93 Million | 158 Thousand | 2.41 Million |
| Inventory | - | - | 3.3 Million | - | -1.54 Million | -1.75 Million |
| Other working capital | -1.8 Million | -13.04 Million | -2.47 Million | -56.9 Million | -19.7 Million | -30.03 Million |
| Cash at beginning of period | 103.21 Million | 111.26 Million | 107.36 Million | 159.52 Million | 115.54 Million | 121.46 Million |
| Cash at end of period | 79.82 Million | 103.21 Million | 111.26 Million | 111.26 Million | 107.36 Million | 115.54 Million |
| Capital Expenditure | - | - | -398 Thousand | -1.93 Million | - | -1.06 Million |
| Effect of forex changes on cash | -1000.00 | -42 Thousand | 71 Thousand | 22 Thousand | -87 Thousand | 39 Thousand |
| Net cash flow / Change in cash | -23.39 Million | -8.05 Million | 3.89 Million | -48.25 Million | -8.17 Million | -5.91 Million |
| Free Cash Flow | -30.51 Million | 11.93 Million | -28.55 Million | -129.09 Million | -32.87 Million | -35.41 Million |
BAYN
IMP
BSEN
MARALOVER
TESI
LV1